We are delighted to announce there will be an International Symposium on ‘Streptococcus agalactiae’ Disease (ISSAD) in Cape Town, South Africa from 20-23 February 2018, held with the generous support of the Bill & Melinda Gates Foundation
Our Chief Executive, Jane Plumb MBE, is a member of the International Scientific Committee, and has been asked to coordinate the session on advocacy for group B Strep prevention strategies, including group B Strep vaccines.
This inaugural symposium will bring together experts and key stakeholders in various fields of GBS for enhanced collaboration, advance the thinking, and exchange ideas aimed at progressing towards a GBS-disease-free population. All researchers, clinicians, healthcare and public health practitioners are welcome to join in sharing ideas, information, science and the future prospects for Group B Streptococcus disease prevention.
The symposium will comprise of a single-stream of oral presentations including a number of plenary talks and free oral papers, together with time slots for posters to be shared. There will also be ample opportunity for informal networking, discussion and debate with fellow professionals in the field.
ISSAD promises to be an interactive and comprehensive platform covering topics ranging from the GBS disease burden and challenges to the epidemiology, immunology and vaccinology of GBS and everything in between. A limited number of travel scholarships will be available for delegates from countries with developing economies.
For more details, see http://issad.co.za/
